journal article·2026-12-31Open access

Network pharmacology analysis of integration of dietary plant-derived natural flavonoids and gut microbiota for the treatment of Polycystic Ovary syndrome (PCOS)

Hong Chen, Hongying Kuang, Yang Zhang, Qionghua Chen, Dongxia Yang

Abstract

Polycystic ovary syndrome (PCOS) is a heterogeneous endocrine disorder manifested by hyperandrogenism, ovulatory dysfunction, and systemic metabolic dysregulation. While the 'gut-diet' axis offers potential therapeutic avenues, the synergistic molecular mechanisms integrating dietary flavonoids and gut microbiota remain elusive. This study employed a comprehensive network pharmacology approach, coupled with molecular docking validation, to decode the tripartite interaction network of 'Dietary Flavonoids-Gut Microbiota-Host Targets.' Our analysis identified Luteolin and Quercetin as critical bioactive mediators that interact with specific gut microbial taxa. Topological network analysis revealed that these compounds exert the effects by targeting pivotal nodes-AKT Serine/Threonine Kinase 1 (AKT1), Epidermal Growth Factor Receptor (EGFR), and Insulin Receptor (INSR). Functional enrichment analysis further demonstrated that these targets converge on the Mitogen-Activated Protein Kinase (MAPK) signalling pathway. Conclusively, this study establishes a systematic theoretical framework for the integrated management of PCOS. Future research should prioritize experimental validation and clinical translation of the findings to develop personalized precision medicines targeting the gut-metabolic axis.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Ovarian function and disorders · Gut microbiota and health · Ginseng Biological Effects and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Graduate School, The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine

Department of Gynecology, Harbin Medical University Cancer Hospital

Graduate School, Heilongjiang University of Chinese Medicine

Department of Gynecology, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine

Department of Internal Medicine, The First Affiliated Hospital of Heilongjiang University of Chinese Medicine

Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xiamen University

Department of Gynecology, The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine

Funding

National Natural Science Foundation of China

References (81)

Show source-provided references
1. 10.1016/j.cnur.2018.04.00810.1016/j.cnur.2018.04.008 ↗
2. 10.1210/er.2015-110410.1210/er.2015-1104 ↗
3. 10.1038/s41572-024-00511-310.1038/s41572-024-00511-3 ↗
4. 10.5802/crbiol.14710.5802/crbiol.147 ↗
5. 10.1016/j.fertnstert.2024.02.00810.1016/j.fertnstert.2024.02.008 ↗
6. 10.1186/s13048-022-01091-010.1186/s13048-022-01091-0 ↗
7. 10.1016/j.tem.2018.11.00110.1016/j.tem.2018.11.001 ↗
8. 10.1128/mSystems.00017-1910.1128/mSystems.00017-19 ↗
9. 10.1097/MD.000000000003607510.1097/MD.0000000000036075 ↗
10. 10.1111/jcmm.1825810.1111/jcmm.18258 ↗
11. 10.1038/s41423-020-00592-610.1038/s41423-020-00592-6 ↗
12. 10.3390/ph1602019710.3390/ph16020197 ↗
13. 10.1007/s00018-018-2943-410.1007/s00018-018-2943-4 ↗
14. 10.1016/j.diabres.2023.11078110.1016/j.diabres.2023.110781 ↗
15. 10.1080/09168451.2018.144446710.1080/09168451.2018.1444467 ↗
16. 10.3390/nu1301020610.3390/nu13010206 ↗
17. 10.1080/21691401.2023.220373410.1080/21691401.2023.2203734 ↗
18. 10.1093/nar/gkab78610.1093/nar/gkab786 ↗
19. 10.1038/nbt128410.1038/nbt1284 ↗
20. 10.1093/nar/gkz38210.1093/nar/gkz382 ↗
21. 10.1089/cmb.2019.032310.1089/cmb.2019.0323 ↗
22. 10.1093/nar/gkw94310.1093/nar/gkw943 ↗
23. 10.1002/cpbi.2710.1002/cpbi.27 ↗
24. 10.1093/nar/gkaa107410.1093/nar/gkaa1074 ↗
25. 10.1093/nar/gkw109210.1093/nar/gkw1092 ↗
26. 10.1186/s12864-018-5209-510.1186/s12864-018-5209-5 ↗
27. 10.1186/s13321-018-0283-x10.1186/s13321-018-0283-x ↗
28. 10.1093/nar/gkae23610.1093/nar/gkae236 ↗
29. 10.1021/acs.molpharmaceut.6b0047110.1021/acs.molpharmaceut.6b00471 ↗
30. 10.1021/acs.chemrestox.5b0046510.1021/acs.chemrestox.5b00465 ↗
31. 10.1093/toxsci/kfac04210.1093/toxsci/kfac042 ↗
32. 10.1016/j.envint.2019.04.06710.1016/j.envint.2019.04.067 ↗
33. 10.1016/j.yrtph.2021.10493510.1016/j.yrtph.2021.104935 ↗
34. 10.1016/j.crtox.2021.05.00210.1016/j.crtox.2021.05.002 ↗
35. 10.2174/138920021866617110815441910.2174/1389200218666171108154419 ↗
36. 10.1016/j.otc.2021.08.00710.1016/j.otc.2021.08.007 ↗
37. 10.1586/17474086.2015.103110610.1586/17474086.2015.1031106 ↗
38. 10.1517/17425255.2014.97016810.1517/17425255.2014.970168 ↗
39. 10.1080/19490976.2022.208596110.1080/19490976.2022.2085961 ↗
40. 10.1007/s12088-022-01019-810.1007/s12088-022-01019-8 ↗
41. 10.1016/j.micpath.2023.10637010.1016/j.micpath.2023.106370 ↗
42. 10.1016/j.intimp.2022.10871710.1016/j.intimp.2022.108717 ↗
43. 10.3389/fphar.2022.100667810.3389/fphar.2022.1006678 ↗
44. 10.3390/nu1305167710.3390/nu13051677 ↗
45. 10.1515/bmc-2020-000510.1515/bmc-2020-0005 ↗
46. 10.3390/nu1419412810.3390/nu14194128 ↗
47. 10.1177/193371911666760610.1177/1933719116667606 ↗
48. 10.1016/j.jep.2024.11827910.1016/j.jep.2024.118279 ↗
49. 10.1186/s13048-025-01737-910.1186/s13048-025-01737-9 ↗
50. 10.1186/s12958-025-01434-810.1186/s12958-025-01434-8 ↗
51. 10.3390/molecules2714447610.3390/molecules27144476 ↗
52. 10.1152/ajpendo.00034.202110.1152/ajpendo.00034.2021 ↗
53. 10.2174/15680090878624105010.2174/156800908786241050 ↗
54. 10.1002/biof.169910.1002/biof.1699 ↗
55. 10.1016/j.biopha.2019.10861210.1016/j.biopha.2019.108612 ↗
56. 10.3390/molecules2708249810.3390/molecules27082498 ↗
57. 10.1002/ptr.714410.1002/ptr.7144 ↗
58. 10.1186/s12958-024-01220-y10.1186/s12958-024-01220-y ↗
59. 10.1080/15384101.2017.138770110.1080/15384101.2017.1387701 ↗
60. 10.1039/d0fo01439g10.1039/d0fo01439g ↗
61. 10.4062/biomolther.2017.25410.4062/biomolther.2017.254 ↗
62. 10.1055/s-0042-11870510.1055/s-0042-118705 ↗
63. 10.1002/ptr.616610.1002/ptr.6166 ↗
64. 10.3390/nu1206162210.3390/nu12061622 ↗
65. 10.3390/antiox1008125110.3390/antiox10081251 ↗
66. 10.1016/j.jnutbio.2021.10892610.1016/j.jnutbio.2021.108926 ↗
67. 10.2337/db08-163710.2337/db08-1637 ↗
68. 10.1177/193371911666721810.1177/1933719116667218 ↗
69. 10.1016/j.metabol.2018.03.00410.1016/j.metabol.2018.03.004 ↗
70. 10.3389/fendo.2023.119175910.3389/fendo.2023.1191759 ↗
71. 10.1038/s41591-019-0509-010.1038/s41591-019-0509-0 ↗
72. 10.3390/nu509336710.3390/nu5093367 ↗
73. 10.1007/s13318-018-0517-310.1007/s13318-018-0517-3 ↗
74. 10.1155/2012/14538010.1155/2012/145380 ↗
75. 10.1002/mnfr.20190095210.1002/mnfr.201900952 ↗
76. 10.1080/19490976.2016.115839510.1080/19490976.2016.1158395 ↗
77. 10.1155/2015/85401510.1155/2015/854015 ↗
78. 10.1097/MCO.000000000000031410.1097/MCO.0000000000000314 ↗
79. 10.1016/j.ijpharm.2006.01.02810.1016/j.ijpharm.2006.01.028 ↗
80. 10.1039/C5RA18896B10.1039/C5RA18896B ↗
81. 10.1002/ptr.228310.1002/ptr.2283 ↗